Is there such a big price gap between the Indian version of Nintedanib and domestic imports? Is the effect the same?

The Indian version of Nintedanib (Nintedanib) includes the Indian original version and the generic version produced by India's Grandmark Pharmaceuticals. The domestically imported nintedanib belongs to the category of original drugs. The ingredients of the original drugs and generic drugs are basically the same, but the manufacturers are different and the prices are different. The original Indian version of Nintedanib has a specification of 150mg*60tablets and the price per box is around RMB 5,900, while the price of the generic version of 150mg*30tablets is around RMB 910 per box (the price may fluctuate due to exchange rates).

Nintedanib, originally developed and produced by Boehringer Ingelheim in Germany, is a small molecule tyrosine kinase inhibitor (TKI) that binds to the growth factor receptor family and prevents the proliferation of fibroblasts. It reduces the ongoing fibrotic process and delays the progression of long-term damage. Nintedanib is a tyrosine kinase inhibitor indicated for the treatment and management of idiopathic pulmonary fibrosis, systemic sclerosis-related interstitial lung disease, and interstitial lung diseases with progressive phenotypes.

The original nintedanib drug marketed in China has entered the scope of Class B medical insurance. The trade name is nintedanib ethanesulfonate soft capsules, but it is limited to patients with idiopathic pulmonary fibrosis (IPF) or systemic sclerosis-related interstitial lung disease (SSc-ILD). SpecificationsThe price of each box of 150mg*30 capsules is around RMB 4,000. The Turkish version of nintedanib original drug, specification priced at around RMB 5,800 per box of 150mg*60 capsules listed overseas (the price may fluctuate due to the exchange rate). For specific prices and drug details, please consult Yaode’s medical consultant.